We also investigated anti-PF4 Ig as autoantibody markers of the thrombotic thrombocytopenic purpura that has been recently described after the adenovirus-based anti–SARS-CoV-2 vaccine. Here, PF4 is linked to thrombotic thrombocytopenic purpura.